Aricept (Donepezil) – Comprehensive Patient Information for Australia
Basic Product Information
| International Non-proprietary Name (INN) | Donepezil |
|---|---|
| Australian Brand Names | Aricept, Aricept Evess (orally disintegrating), Donepezil Sandoz, Donepezil Apotex, others |
| ATC Code | N06DA02 |
| Available Forms & Strengths | Film-coated tablets: 5 mg, 10 mg; Orally disintegrating tablets: 5 mg, 10 mg |
| Manufacturers | Pfizer Australia, Sandoz, Apotex, Alphapharm, various generics |
| Prescription Status | Prescription Only Medicine (Schedule 4 – S4) |
Mechanism of Action
For Patients: Aricept (donepezil) is used to manage symptoms of Alzheimer's disease. It helps by improving nerve signals in the brain that are often reduced in people with dementia. Donepezil works by boosting the levels of a chemical messenger called acetylcholine, which plays a key role in memory, thinking, and reasoning.
For Specialists: Donepezil is a reversible acetylcholinesterase inhibitor. It increases acetylcholine concentrations in cortical synapses by blocking the breakdown mediated by acetylcholinesterase, thus enhancing cholinergic transmission. This mechanism underpins its therapeutic effects in Alzheimer's disease and some other dementias.
Pharmacokinetics
- Absorption: Rapidly absorbed after oral administration; peak plasma concentrations reached within 3–5 hours.
- Metabolism: Extensively metabolised in the liver by CYP2D6 and CYP3A4 enzymes; minor pathways involve glucuronidation and hydrolysis.
- Elimination: Elimination half-life approximately 70 hours; excreted via urine and, to a lesser extent, faeces.
- Duration of Action: Therapeutic effects last approximately 24 hours; steady-state concentrations achieved in 2–3 weeks with daily dosing.
Use in Everyday Life and Best Practices
- Typical Doses: Initial dose is 5 mg taken once daily, usually increased to 10 mg daily after four weeks if tolerated and as per doctor’s advice.
- How to Use: Swallow tablets whole with water. Orally disintegrating tablets may be placed on the tongue and allowed to dissolve before swallowing.
- English Context: Patients are encouraged to take their medication regularly as prescribed, and to attend regular medical reviews for ongoing assessment and support.
Dosing in the Morning vs Evening
- Evening Dosing (Preferred): In Australia and internationally, evening dosing is recommended as it may reduce the risk of certain side effects (especially nausea) by promoting sleep during the peak plasma concentrations.
- Morning Dosing: For patients experiencing insomnia or vivid dreams as a side effect, morning dosing may be considered. Always discuss changes with a healthcare provider.
- Tips for Regularity: Take Aricept at the same time each day to maintain consistent blood levels and avoid missed doses. Use pill organisers or phone reminders if needed.
Taking with Food or on an Empty Stomach
Aricept can be taken with or without food. Taking with food may help reduce stomach upset, though this is not common. English diet habits (typically including breakfast, lunch, and dinner at regular intervals) allow for flexible timing. Patients are advised to choose a routine that suits their daily life and reduces gastrointestinal side effects.
Interaction Warnings
Patients should always inform their doctor and pharmacist about other medications they are taking.
| Type | Important Interactions | Details |
|---|---|---|
| Medications | Anticholinergic drugs | Reduce Aricept effectiveness (e.g., oxybutynin, tolterodine) |
| Medications | Cholinergic agonists | May increase cholinergic side effects |
| Medications | CYP2D6/3A4 inhibitors/inducers | Alter donepezil levels (e.g., ketoconazole increases, rifampicin decreases) |
| Medications | Non-steroidal anti-inflammatory drugs (NSAIDs) | Increased risk of gastrointestinal irritation/bleeding |
| Food | Grapefruit juice | Potential to raise donepezil levels; caution advised |
| Alcohol | Excessive alcohol intake | May impair cognition and counteract Aricept’s benefits |
This is not an exhaustive list; consult your pharmacist or GP if unsure.
Indications
| Indication | Status in Australia |
|---|---|
| Symptomatic treatment of mild to moderate Alzheimer's disease | Approved / PBS reimbursed |
| Dementia with Lewy bodies | Off-label (limited specialist guidance/support) |
| Vascular dementia | Off-label, not routinely recommended |
| Other cognitive disorders (e.g., Parkinson’s disease dementia, severe Alzheimer's) | Individualised, off-label use with specialist recommendation |
Dosing According to Clinical Indications
| Patient Group | Initial Dose | Maintenance Dose | Max Dose |
|---|---|---|---|
| Adults (Alzheimer’s disease) | 5 mg once daily | 10 mg once daily after at least 4 weeks | 10 mg/day |
| Elderly | 5 mg once daily | 10 mg once daily if tolerated | 10 mg/day |
| Paediatrics (under 18) | Not recommended for routine use | Off-label only; specialist guidance required | — |
| Renal/hepatic impairment | 5 mg once daily | Cautious titration, monitor closely | 10 mg/day |
Safety Profile and Side Effects
| Frequency | Possible Side Effects |
|---|---|
| Very Common | Nausea, diarrhoea, headache, insomnia |
| Common | Muscle cramps, fatigue, weight loss, loss of appetite, vomiting |
| Uncommon/Rare | Bradycardia, syncope (fainting), hallucinations, agitation, skin rash, abnormal liver tests |
| Serious/Warned | Heart rhythm disturbances, severe allergic reactions (rare: swelling, breathing difficulties), gastrointestinal bleeding—seek urgent medical attention |
- Most side effects are mild and temporary, especially when starting treatment or increasing the dose.
- Report severe or persistent symptoms to your doctor.
- Patients with heart disease or peptic ulcers require extra monitoring.
Guidelines for Proper Use: Pharmacy & Clinic Advice
- Take Aricept exactly as your doctor prescribes. Do not increase or stop the dose without medical advice.
- If you forget a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed tablet. Never double the dose to catch up.
- Attend regular reviews with your GP or dementia specialist to monitor your progress and side effects.
- Store the medication at room temperature, away from moisture, heat, and direct sunlight. Keep out of reach of children.
- Driving: Donepezil can cause dizziness or drowsiness; avoid operating machinery or driving until you know how it affects you.
- For those caring for someone with dementia, use weekly pill organisers and consider medication reminders.
Alternative Treatment Options
- Galantamine (Reminyl®) – Another cholinesterase inhibitor, PBS listed, similar efficacy but different side-effect profile.
- Rivastigmine (Exelon®) – Available as oral capsules and skin patches; often considered if oral medications are not tolerated.
- Memantine (Ebixa®) – NMDA receptor antagonist; used for moderate to severe Alzheimer’s (can be used in conjunction with Aricept in some cases).
- Non-drug Options: Cognitive stimulation therapy, occupational therapy, physical activity, and nutritional support are all recommended adjuncts in Australia.
Your GP or dementia specialist can discuss which treatment is best for your situation.
Legal, Registration, and Reimbursement Status in Australia
- Registration: Registered by the Therapeutic Goods Administration (TGA).
- Prescription Classification: S4 – Prescription Only Medicine.
- Reimbursement: Approved on the Pharmaceutical Benefits Scheme (PBS) for mild to moderate Alzheimer’s disease when prescribed according to guidelines.
- Supply: Dispensed by community and hospital pharmacies upon presentation of a valid prescription.
Latest Research & Clinical Guidance (2022–2025)
- Effectiveness: Latest international studies (see: BMJ 2023) confirm donepezil remains beneficial in managing memory, behaviour, and function in Alzheimer’s disease, although the benefit is modest and does not halt disease progression.
- Safety: Real-world Australian data (AUS-AD study, 2024) indicate no significant new safety concerns but highlight the need for cardiovascular monitoring in the elderly.
- Guidelines: Australian Dementia Guidelines (2024, Dementia Australia) recommend donepezil as first-line pharmacotherapy for symptomatic Alzheimer’s disease, with rivastigmine/galantamine as alternatives.
- Emerging Research: No approved disease-modifying therapies for Alzheimer's are available in Australia as of 2025; ongoing surveillance for amyloid-targeted therapies is recommended.
Availability and Delivery in Australia
| Pack Size | Indicative PBS Patient Price | Delivery Times (major cities) |
|---|---|---|
| 30 tablets (one month’s supply) | $6.70 (concession), $42.50 (general) | Sydney: 0–1 business days Melbourne: 1 business day Brisbane: 1 business day Perth: 2–4 business days Adelaide: 1–2 business days |
| 90 tablets (three months) | $20.10 (concession), $127.50 (general fee out-of-pocket max) | As above; regional/remote areas 2–7 business days |
Prices are PBS-controlled and may vary slightly. Private scripts cost more. Most major pharmacies offer click and collect or home delivery options.
Frequently Asked Questions (FAQ)
- How long does it take for Aricept to start working?
Some improvement may be noticed after a few weeks of daily use, but the maximum effect is usually seen after 2–3 months. Not all patients or families notice obvious changes. - Can Aricept cure Alzheimer’s disease?
No. Donepezil helps manage the symptoms and maintain mental function for longer, but it does not cure Alzheimer’s disease or reverse existing damage. - Is it safe to stop Aricept suddenly?
Do not stop donepezil abruptly without consulting your doctor. Symptoms may worsen or return. Your doctor can advise on tapering if stopping is necessary. - Can Aricept be taken with other dementia medications?
It may be combined with memantine in some cases. Never combine with other cholinesterase inhibitors unless under specialist care. - What should I do if I miss a dose?
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one—do not double up. If you miss multiple days, consult your doctor before restarting.
Further Information
Talk to your pharmacist or GP for further support or if you have any questions regarding Aricept or dementia care. Reliable resources include Healthdirect Australia and Dementia Australia.
